GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Sale Of Investment

Fisher & Paykel Healthcare (NZSE:FPH) Sale Of Investment : NZ$0 Mil (TTM As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Sale Of Investment?

Fisher & Paykel Healthcare's sale of investment for the six months ended in Sep. 2023 was NZ$0 Mil. It means Fisher & Paykel Healthcare gained NZ$0 Mil from selling investments. Fisher & Paykel Healthcare's sale of investment for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$0 Mil.

Compared with last quarter (NZ$0 Mil in Mar. 2023 ), Fisher & Paykel Healthcare gained the same money from selling investments in Sep. 2023 (NZ$0 Mil).

Fisher & Paykel Healthcare Sale Of Investment Historical Data

The historical data trend for Fisher & Paykel Healthcare's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Sale Of Investment Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.50 15.00 - 80.30 200.00

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.10 -14.80 200.00 - -

Fisher & Paykel Healthcare Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Sale Of Investment
Comparable Companies
ASX:HGL ASX:AVJ ASX:CWP ASX:UOS ASX:PPC ASX:TIA ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN XPAR:DIM BAX HOLX COO
Traded in Other Exchanges
FSPKF:USA FPLB:Germany FPH:Australia
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Website
https://www.fphcare.com
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.